Argus Downgrades Hologic to Hold
Argus downgraded Hologic (HOLX) to Hold from Buy as the company had agreed in October to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B. The transaction is expected to close in early February, the analyst tells investors in a research note.